InvestorsHub Logo
Post# of 252255
Next 10
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

Re: genisi post# 169196

Saturday, 11/02/2013 3:36:34 PM

Saturday, November 02, 2013 3:36:34 PM

Post# of 252255

Even if the oral had been 10% less potent, would you not prefer it?





Even 15% lower efficacy would be a fair trade off IMO.


I'm anxious to see the results from the Phase-3B study comparing both options.







Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.